
ALDH3A1-IN-1
CAS No. 1039855-56-5
ALDH3A1-IN-1( —— )
Catalog No. M35409 CAS No. 1039855-56-5
ALDH3A1-IN-1 (Compound 18) is a potent ALDH3A1 inhibitor with an IC 50 of 1.61 μM. It is more effective than DEAB against patient-derived primary prostate tumor epithelial cells, both as a single agent and in combination with docetaxel .
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameALDH3A1-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionALDH3A1-IN-1 (Compound 18) is a potent ALDH3A1 inhibitor with an IC 50 of 1.61 μM. It is more effective than DEAB against patient-derived primary prostate tumor epithelial cells, both as a single agent and in combination with docetaxel .
-
DescriptionALDH3A1-IN-1 (Compound 18) is a potent inhibitor of ALDH3A1 with an IC50 of 1.61 μM. ALDH3A1-IN-1 is more potent than DEAB against patient-derived primary prostate tumor epithelial cells, as single agents or in combination research with docetaxel.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
RecptorNMDAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1039855-56-5
-
Formula Weight250.29
-
Molecular FormulaC13H18N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (399.54 mM; Ultrasonic (<60°C)
-
SMILESCCCN(CCC)c1ccc(C=O)cc1[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ibrahim AIM, et al. Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer. J Med Chem. 2022 Mar 10;65(5):3833-3848.?
molnova catalog



related products
-
Tiletamine hydrochlo...
Proposed anesthetic with possible anticonvulsant and sedative properties.
-
Ro 25-6981 Maleate
Ro 25-6981 Maleate is a potent and selective activity-dependent NMDA receptor blocker, specifically targeting the NR2B subunit (IC50 values are 0.009 μM for NR1C/NR2B and 52 μM for NR1C/NR2A receptor subunit combinations).
-
TCN-201
TCN-201 is a selective antagonist of NMDA receptors containing the NR2A subunit.